LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,966 | -56.9% | 12,902 | -6.8% | 0.00% | – |
| Q2 2023 | $44,021 | -97.5% | 13,843 | -97.3% | 0.00% | -100.0% |
| Q4 2022 | $1,780,804 | -52.7% | 513,200 | -0.0% | 0.01% | -54.5% |
| Q3 2022 | $3,762,000 | +12.4% | 513,201 | +0.0% | 0.01% | +22.2% |
| Q2 2022 | $3,346,000 | +29.1% | 513,200 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $2,592,000 | +62.9% | 513,200 | +149.7% | 0.01% | +100.0% |
| Q4 2021 | $1,591,000 | -79.3% | 205,500 | -60.4% | 0.00% | -80.0% |
| Q3 2021 | $7,681,000 | -19.6% | 519,000 | -11.8% | 0.02% | -16.7% |
| Q2 2021 | $9,553,000 | – | 588,235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |